The value of patient-reported outcome measures for multiple sclerosis.
作者信息
McGinley Marisa P, Lapin Brittany
机构信息
Cleveland Clinic, Cleveland, OH, USA.
Center for Outcomes Research and Evaluation, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA/Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Mult Scler. 2022 Sep;28(10):1489-1490. doi: 10.1177/13524585221111675.
Abstract
摘要
相似文献
1
The value of patient-reported outcome measures for multiple sclerosis.患者报告的多发性硬化症结局指标的价值
Mult Scler. 2022 Sep;28(10):1489-1490. doi: 10.1177/13524585221111675.
2
Otolaryngological symptoms and multiple sclerosis: A forgotten and underestimated relationship.耳鼻喉科症状与多发性硬化症：一种被遗忘且被低估的关系。
Mult Scler Relat Disord. 2019 Feb;28:197-198. doi: 10.1016/j.msard.2019.01.010. Epub 2019 Jan 3.
3
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.减轻调查负担：多发性硬化症患者报告结局测量信息系统（PROMIS）量表的可行性和有效性
Mult Scler. 2014 Jul;20(8):1102-11. doi: 10.1177/1352458513517279. Epub 2014 Jan 8.
4
Patient-reported questionnaires in MS rehabilitation: responsiveness and minimal important difference of the multiple sclerosis questionnaire for physiotherapists (MSQPT).多发性硬化症康复中患者报告的问卷：物理治疗师多发性硬化症问卷（MSQPT）的反应度和最小重要差异
BMC Neurol. 2017 Mar 16;17(1):50. doi: 10.1186/s12883-017-0834-1.
5
Patient-Reported Outcome Measures in Systemic Sclerosis (Scleroderma).系统性硬化症（硬皮病）患者报告的结局指标
Rheum Dis Clin North Am. 2016 May;42(2):301-16. doi: 10.1016/j.rdc.2016.01.003. Epub 2016 Mar 16.
6
Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done!多发性硬化症的多学科数据基础设施：为什么需要它们以及如何实现！
Mult Scler. 2019 Apr;25(4):500-509. doi: 10.1177/1352458518807076. Epub 2018 Nov 1.
7
Motherhood choice in multiple sclerosis (MoMS) development and piloting of patient-reported outcome measures.多发性硬化症患者生育选择（MoMS）研究的发展和患者报告结局测量指标的初步研究。
Mult Scler Relat Disord. 2022 Jul;63:103831. doi: 10.1016/j.msard.2022.103831. Epub 2022 Apr 27.
8
A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol.荷兰一项基于网络的前瞻性以患者为中心的互动研究，涉及多发性硬化症患者的长期残疾、残疾认知及健康相关生活质量：荷兰多发性硬化症研究方案
BMC Neurol. 2015 Aug 4;15:128. doi: 10.1186/s12883-015-0379-0.
9
Patient perspectives on patient-reported outcomes in multiple sclerosis treatment trajectories: A qualitative study of why, what, and how?患者对多发性硬化症治疗轨迹中患者报告结局的看法：一项关于为何、什么以及如何进行的定性研究？
Mult Scler Relat Disord. 2022 Feb;58:103475. doi: 10.1016/j.msard.2021.103475. Epub 2021 Dec 27.
10
Living with multiple sclerosis: A Jordanian perspective.从约旦视角看多发性硬化症患者的生活
Physiother Res Int. 2018 Apr;23(2):e1709. doi: 10.1002/pri.1709. Epub 2018 Mar 9.
引用本文的文献
1
Exercise-based telerehabilitation for patients with multiple sclerosis using physical activity: a systematic review.基于运动的多发性硬化症远程康复治疗：一项系统评价。
J Rehabil Med. 2024 Nov 13;56:jrm40641. doi: 10.2340/jrm.v56.40641.
2
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.早期复发缓解型多发性硬化症患者的绝望感
Patient Prefer Adherence. 2023 Jun 14;17:1431-1439. doi: 10.2147/PPA.S411069. eCollection 2023.
本文引用的文献
1
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.多发性硬化症进展期临床试验中的 MSIS-29 和 SF-36 作为结局指标。
Mult Scler. 2022 Sep;28(10):1606-1619. doi: 10.1177/13524585221105465.
2
Quality of life in adults with multiple sclerosis: a systematic review.多发性硬化症成人患者的生活质量：系统评价。
BMJ Open. 2020 Nov 30;10(11):e041249. doi: 10.1136/bmjopen-2020-041249.
3
Patient-reported outcomes in the spotlight.患者报告的结局成为焦点。
Lancet Neurol. 2019 Nov;18(11):981. doi: 10.1016/S1474-4422(19)30357-6.
4
Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?用于解释群组水平患者报告结局数据的方法能否应用于个体患者管理？
Med Care. 2019 May;57 Suppl 5 Suppl 1(Suppl 5 1):S38-S45. doi: 10.1097/MLR.0000000000001111.
5
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.那他珠单抗治疗继发进展型多发性硬化症的疗效（ASCEND）：一项开放标签扩展的 3 期、随机、双盲、安慰剂对照试验。
Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12.
6
Evaluating Individual Change With the Quality of Life in Neurological Disorders (Neuro-QoL) Short Forms.使用神经疾病生活质量简表（Neuro-QoL）评估个体变化。
Arch Phys Med Rehabil. 2016 Apr;97(4):650-654.e8. doi: 10.1016/j.apmr.2015.12.010. Epub 2015 Dec 29.
7
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.提炼评估的精髓：一项针对多发性硬化症患者的混合方法研究。
Qual Life Res. 2016 Apr;25(4):793-805. doi: 10.1007/s11136-015-1119-z. Epub 2015 Sep 5.
8
Investigating the minimal important difference in ambulation in multiple sclerosis: a disconnect between performance-based and patient-reported outcomes?探究多发性硬化症步行能力的最小重要差异：基于表现的结果与患者报告的结果之间的脱节？
J Neurol Sci. 2014 Dec 15;347(1-2):268-74. doi: 10.1016/j.jns.2014.10.021. Epub 2014 Oct 18.
9
Data mining for response shift patterns in multiple sclerosis patients using recursive partitioning tree analysis.应用递归分区树分析挖掘多发性硬化症患者的反应转移模式数据。
Qual Life Res. 2011 Dec;20(10):1543-53. doi: 10.1007/s11136-011-0004-7. Epub 2011 Sep 11.
Zotero 插件